Studies have reported its high expression in acute myeloid leukemia (AML), promoting cellular transformation and proliferation by the post-transcriptional regulation of ASB2, RARA, MYC, and CEBPA [61, 62]. This evidence concerns the gene ASB2 and acute myeloid leukemia.